Capital Fund Management (CFM)
JAZZ icon

Capital Fund Management (CFM)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Capital Fund Management (CFM)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-40,275
Closed -$4.27M – 2575
2025
Q2 		$4.27M Buy
+40,275
New +$4.37M 0.01% 1246
2020
Q3 		– Sell
-11,708
Closed -$1.29M – 1298
2020
Q2 		$1.29M Sell
11,708
-1,899
-14% -$210K 0.02% 626
2020
Q1 		$1.36M Sell
13,607
-26,143
-66% -$3.38M 0.02% 661
2019
Q4 		$5.93M Buy
39,750
+32,057
+417% +$4.36M 0.05% 483
2019
Q3 		$986K Buy
7,693
+1,806
+31% +$242K 0.01% 1026
2019
Q2 		$839K Sell
5,887
-18,500
-76% -$2.49M 0.01% 1068
2019
Q1 		$3.49M Sell
24,387
-13,300
-35% -$1.73M 0.03% 616
2018
Q4 		$4.67M Buy
37,687
+33,979
+916% +$5.04M 0.04% 533
2018
Q3 		$623K Buy
+3,708
New +$638K ﹤0.01% 1523
2018
Q2 		– Sell
-3,592
Closed -$587K – 2131
2018
Q1 		$542K Sell
3,592
-4,178
-54% -$613K ﹤0.01% 1435
2017
Q4 		$1.05M Buy
+7,770
New +$1.08M 0.01% 1204
2016
Q4 		– Sell
-47,483
Closed -$5.77M – 1761
2016
Q3 		$5.77M Sell
47,483
-26,244
-36% -$3.54M 0.05% 420
2016
Q2 		$10.4M Buy
73,727
+39,673
+117% +$5.85M 0.1% 252
2016
Q1 		$4.45M Sell
34,054
-654
-2% -$81.4K 0.04% 470
2015
Q4 		$4.88M Buy
34,708
+19,603
+130% +$2.72M 0.05% 450
2015
Q3 		$2.01M Sell
15,105
-929
-6% -$160K 0.02% 618
2015
Q2 		$2.82M Buy
16,034
+14,417
+892% +$2.59M 0.04% 508
2015
Q1 		$279K Buy
+1,617
New +$278K ﹤0.01% 1262
2014
Q2 		– Sell
-32,625
Closed -$4.52M – 1801
2014
Q1 		$4.52M Buy
+32,625
New +$4.91M 0.06% 402

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Capital Fund Management (CFM)'s JAZZ Position: Q3 2025 in Review

Capital Fund Management (CFM) sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2025, closing a stake of 40,275 shares — an estimated $4.27M sold.

Capital Fund Management (CFM) first reported a position in JAZZ in Q1 2014 and held it in 19 quarters. The position peaked at $10.4M in Q2 2016. 503 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.

  • Capital Fund Management (CFM) reported no remaining Jazz Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 40,275 Jazz Pharmaceuticals shares in Q3 2025, an estimated $4.27M.
  • Capital Fund Management (CFM) first reported a position in Jazz Pharmaceuticals in Q1 2014 and held it in 19 quarters.
  • Capital Fund Management (CFM)'s Jazz Pharmaceuticals position peaked at $10.4M in Q2 2016.
  • 503 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2025, filed 13 Nov 2025.